... Other targeted therapy drugs such as Adcetris (brentuximab vedotin) and Folotyn (pralatrexate) may also be used.Clinical TrialsOngoing clinical trials for AITL treatment using existing and experimental drugs may be another option for treatment. Clinical trials test the effectiveness of various drugs, sometimes in conjunction with chemotherapy. ...
... Other targeted therapy drugs such as Adcetris (brentuximab vedotin) and Folotyn (pralatrexate) may also be used.Clinical TrialsOngoing clinical trials for AITL treatment using existing and experimental drugs may be another option for treatment. Clinical trials test the effectiveness of various drugs, sometimes in conjunction with chemotherapy. ...
... Another immunotherapy drug, Adcetris (brentuximab vedotin), may also be used for relapsed or refractory disease or for newly diagnosed stage 3 or stage 4 cHL.Other cHL Treatment OptionsPeople with relapsed or refractory cHL may need different treatment plans that consist of higher treatment doses or other medications. ...
... Another immunotherapy drug, Adcetris (brentuximab vedotin), may also be used for relapsed or refractory disease or for newly diagnosed stage 3 or stage 4 cHL.Other cHL Treatment OptionsPeople with relapsed or refractory cHL may need different treatment plans that consist of higher treatment doses or other medications. ...
... doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin, and prednisone (a corticosteroid)CHOEP — Cyclophosphamide, doxorubicin, vincristine sulfate (formally sold as Oncovin), etoposide (also known as VP-16), and prednisoneCHOP — Cyclophosphamide, doxorubicin, vincristine sulfate, and prednisoneTargeted immunotherapy for ALCL may include Adcetris ...
... doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin, and prednisone (a corticosteroid)CHOEP — Cyclophosphamide, doxorubicin, vincristine sulfate (formally sold as Oncovin), etoposide (also known as VP-16), and prednisoneCHOP — Cyclophosphamide, doxorubicin, vincristine sulfate, and prednisoneTargeted immunotherapy for ALCL may include Adcetris ...
... Targeted antibodies include monoclonal antibodies (which target one specific pathway, such as the cells’ ability to grow) and antibody-drug conjugates (an anticancer drug combined with an antibody to deliver the drug specifically to cancer cells).Antibody-drug conjugates include: Adcetris (brentuximab vedotin) — Approved for people with Hodgkin or non-Hodgkin ...
... Targeted antibodies include monoclonal antibodies (which target one specific pathway, such as the cells’ ability to grow) and antibody-drug conjugates (an anticancer drug combined with an antibody to deliver the drug specifically to cancer cells).Antibody-drug conjugates include: Adcetris (brentuximab vedotin) — Approved for people with Hodgkin or non-Hodgkin ...
... Spelled out, ABVD includes the medications: Doxorubicin (Adriamycin or Rubex) Bleomycin (Blenoxane) Vinblastine (Velbane) Dacarbazine (DTIC-Dome) Newer drugs that can also be used include: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Brentuximab (Adcetris) In cases that are more difficult to treat, a person with LRHL may undergo a stem cell transplant ...
... Spelled out, ABVD includes the medications: Doxorubicin (Adriamycin or Rubex) Bleomycin (Blenoxane) Vinblastine (Velbane) Dacarbazine (DTIC-Dome) Newer drugs that can also be used include: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Brentuximab (Adcetris) In cases that are more difficult to treat, a person with LRHL may undergo a stem cell transplant ...
... Brentuximab vedotin (Adcetris) has been used to treat advanced cutaneous T-cell lymphoma. It works by targeting an antigen found on cancerous T cells. Chemotherapy While often used in combination to treat other cancers, chemotherapy agents are often used as “single agents” — one at a time — to treat cutaneous T-cell lymphoma. ...
... Brentuximab vedotin (Adcetris) has been used to treat advanced cutaneous T-cell lymphoma. It works by targeting an antigen found on cancerous T cells. Chemotherapy While often used in combination to treat other cancers, chemotherapy agents are often used as “single agents” — one at a time — to treat cutaneous T-cell lymphoma. ...
... Some of the chemotherapy drugs most likely to cause CIPN include: Brentuximab vedotin (Adcetris) Vincristine (formerly sold as Oncovin) bortezomib (Velcade) Platinum-based drugs like cisplatin (Platinol) and carboplatin (Paraplatin) CIPN develops in 30 percent to 40 percent of people who undergo cancer treatment. ...
... Some of the chemotherapy drugs most likely to cause CIPN include: Brentuximab vedotin (Adcetris) Vincristine (formerly sold as Oncovin) bortezomib (Velcade) Platinum-based drugs like cisplatin (Platinol) and carboplatin (Paraplatin) CIPN develops in 30 percent to 40 percent of people who undergo cancer treatment. ...
... Examples of ADCs include: Brentuximab vedotin (Adcetris) Loncastuximab tesirine-lpyl (Zynlonta) Polatuzumab vedotin-piiq (Polivy) Immune Checkpoint InhibitorsImmune checkpoint inhibitors are drugs that strengthen the immune system’s response to cancer cells. Normally, the immune system uses checkpoint proteins to keep from attacking healthy cells. ...
... Examples of ADCs include: Brentuximab vedotin (Adcetris) Loncastuximab tesirine-lpyl (Zynlonta) Polatuzumab vedotin-piiq (Polivy) Immune Checkpoint InhibitorsImmune checkpoint inhibitors are drugs that strengthen the immune system’s response to cancer cells. Normally, the immune system uses checkpoint proteins to keep from attacking healthy cells. ...
Join